Growington Ventures India Board Meeting Outcome

Growington Ventures India Other Announcement

The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.

Growington Ventures India Other Announcement

Growington Ventures India declared Reg 57(5) non-applicable for Q1 FY27. No non-convertible securities exist, so no interest or principal obligations were due or unpaid.

Growington Ventures India Merger & Restructuring Worth ₹1.28 Cr

Growington Ventures India Ltd's board approved an investment of USD 152,183 (approx. ₹1.28 Crore) in its wholly-owned subsidiary, Elementures Foodstuff Trading LLC.

Value

₹1.28 Cr

Growington Ventures India Q1 FY27 Results: Net Profit ₹1.8 Cr, Down 14.3% YoY

Growington Ventures India Ltd reported revenue from operations of ₹47.9 Cr (+190.3% YoY) and net profit of ₹1.8 Cr (-14.3% YoY) for Q1 FY27.

Key figure

Net profit ₹1.8 Cr · -14.3% YoY

Growington Ventures India Board Meeting Date

Growington Ventures India Limited has scheduled a board meeting for August 6, 2026, to consider and approve its un-audited standalone and consolidated financial results.

Growington Ventures India Debt & Borrowing: ₹1.89 Cr

Growington Ventures India Limited approved an overdraft facility of ₹1.89 Crore from ICICI Bank against a fixed deposit security.

Value

₹1.89 Cr

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.